Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists - A real-world analysis using the FDA adverse event reporting system
Favorite
Share
More Options
14

Open in WPS to view all 14 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
